Skip to content

Clinical trials

Completed Lung Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Completed Country / region: South Korea Clear all

95 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20052
20064
20072
20085
20094
20103
20116
20125
20134
20143
201510
20166
20174
20188
20195
20205
20219
20222
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed95

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yonsei University8
AstraZeneca7
Novartis Pharmaceuticals7
Samsung Medical Center7
National Cancer Center, Korea6
Chonnam National University Hospital5
Pfizer4
Seoul National University Hospital4
Bristol-Myers Squibb3
Incyte Corporation3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms95
Carcinoma, Non-Small-Cell Lung41
Neoplasms11
Adenocarcinoma of Lung6
Lung Diseases6
Neoplasm Metastasis6
Adenocarcinoma5
Carcinoma5
Respiratory Tract Diseases5
Colorectal Neoplasms4

Trials

Showing 1 to 25 of 95. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.